Ligand Pharmaceuticals (LGND) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.75% |
| Dec 31, 2025 | -3.23% |
| Sep 30, 2025 | 47.50% |
| Jun 30, 2025 | 27.58% |
| Mar 31, 2025 | 4.15% |
| Dec 31, 2024 | -50.41% |
| Sep 30, 2024 | 37.17% |
| Jun 30, 2024 | 50.80% |
| Mar 31, 2024 | 28.19% |
| Dec 31, 2023 | -16.89% |
| Sep 30, 2023 | -4.48% |
| Jun 30, 2023 | 21.51% |
| Mar 31, 2023 | -79.65% |
| Dec 31, 2022 | 131.36% |
| Sep 30, 2022 | 32.61% |
| Jun 30, 2022 | 5.03% |
| Mar 31, 2022 | -13.11% |
| Dec 31, 2021 | 6.70% |
| Sep 30, 2021 | -4.52% |
| Jun 30, 2021 | 21.55% |
| Mar 31, 2021 | -15.74% |
| Dec 31, 2020 | 28.88% |
| Sep 30, 2020 | 5.18% |
| Jun 30, 2020 | 30.18% |
| Mar 31, 2020 | -10.27% |
| Dec 31, 2019 | 0.05% |
| Sep 30, 2019 | -4.17% |
| Jun 30, 2019 | 22.89% |
| Mar 31, 2019 | -11.02% |
| Dec 31, 2018 | 9.85% |
| Sep 30, 2018 | 13.67% |
| Jun 30, 2018 | 5.64% |
| Mar 31, 2018 | -49.38% |
| Dec 31, 2017 | 71.46% |
| Sep 30, 2017 | 13.49% |
| Jun 30, 2017 | -23.51% |
| Mar 31, 2017 | 16.18% |
| Dec 31, 2016 | 5.67% |
| Sep 30, 2016 | 5.94% |
| Jun 30, 2016 | 12.87% |
| Mar 31, 2016 | 39.74% |
| Dec 31, 2015 | 3.91% |
| Sep 30, 2015 | -24.59% |
| Jun 30, 2015 | 29.07% |
| Mar 31, 2015 | 17.74% |
| Dec 31, 2014 | -33.14% |
| Sep 30, 2014 | 22.34% |
| Jun 30, 2014 | 46.40% |
| Mar 31, 2014 | 36.26% |
| Dec 31, 2013 | -1.04% |
| Sep 30, 2013 | 2.75% |
| Jun 30, 2013 | 32.74% |
| Mar 31, 2013 | 18.19% |
| Dec 31, 2012 | -6.12% |
| Sep 30, 2012 | -27.33% |
| Jun 30, 2012 | 96.61% |
| Mar 31, 2012 | 0.57% |
| Dec 31, 2011 | -25.79% |
| Sep 30, 2011 | -22.19% |
| Jun 30, 2011 | 170.13% |
| Mar 31, 2011 | 45.34% |
| Dec 31, 2010 | -44.17% |